Afatinib Versus Osimertinib as First-Line Treatment for Advanced EGFR-Mutant Non-Small-Cell Lung Cancer: A 3-Year Follow-Up Overall Survival Analysis.

Saved in:
Bibliographic Details
Title: Afatinib Versus Osimertinib as First-Line Treatment for Advanced EGFR-Mutant Non-Small-Cell Lung Cancer: A 3-Year Follow-Up Overall Survival Analysis.
Authors: Huang YH; Department of Chest Medicine, Taichung Veterans General Hospital, No. 1650, Sect. 4, Taiwan Boulevard, Taichung, 407, Taiwan.; Lung Cancer Comprehensive Care and Research Center, Taichung Veterans General Hospital, No. 1650, Sect. 4, Taiwan Boulevard, Taichung, 407, Taiwan.; School of Medicine, College of Medicine, National Yang Ming Chiao Tung University, No. 155, Sect. 2, Linong St., Taipei, 112, Taiwan., Hsu KH; Department of Chest Medicine, Taichung Veterans General Hospital, No. 1650, Sect. 4, Taiwan Boulevard, Taichung, 407, Taiwan.; Lung Cancer Comprehensive Care and Research Center, Taichung Veterans General Hospital, No. 1650, Sect. 4, Taiwan Boulevard, Taichung, 407, Taiwan., Tseng JS; Department of Chest Medicine, Taichung Veterans General Hospital, No. 1650, Sect. 4, Taiwan Boulevard, Taichung, 407, Taiwan.; Lung Cancer Comprehensive Care and Research Center, Taichung Veterans General Hospital, No. 1650, Sect. 4, Taiwan Boulevard, Taichung, 407, Taiwan.; School of Medicine, College of Medicine, National Yang Ming Chiao Tung University, No. 155, Sect. 2, Linong St., Taipei, 112, Taiwan.; Department of Post-Baccalaureate Medicine, College of Medicine, National Chung Hsing University, No. 145, Xingda Rd., South Dist., Taichung, 402, Taiwan.; Institute of Biomedical Sciences, National Chung Hsing University, No. 145, Xingda Rd., South Dist., Taichung, 402, Taiwan., Lee PH; Department of Chest Medicine, Taichung Veterans General Hospital, No. 1650, Sect. 4, Taiwan Boulevard, Taichung, 407, Taiwan.; Lung Cancer Comprehensive Care and Research Center, Taichung Veterans General Hospital, No. 1650, Sect. 4, Taiwan Boulevard, Taichung, 407, Taiwan.; School of Medicine, College of Medicine, National Yang Ming Chiao Tung University, No. 155, Sect. 2, Linong St., Taipei, 112, Taiwan.; Doctoral Program in Translational Medicine, National Chung Hsing University, No. 145, Xingda Rd., South Dist., Taichung, 402, Taiwan.; Rong Hsing Translational Medicine Research Center, National Chung Hsing University, No. 145, Xingda Rd., South Dist., Taichung, 402, Taiwan., Lin IH; Department of Chest Medicine, Taichung Veterans General Hospital, No. 1650, Sect. 4, Taiwan Boulevard, Taichung, 407, Taiwan., Peng MH; Department of Chest Medicine, Taichung Veterans General Hospital, No. 1650, Sect. 4, Taiwan Boulevard, Taichung, 407, Taiwan., Yang TY; Department of Chest Medicine, Taichung Veterans General Hospital, No. 1650, Sect. 4, Taiwan Boulevard, Taichung, 407, Taiwan. jonyin@gmail.com.; Lung Cancer Comprehensive Care and Research Center, Taichung Veterans General Hospital, No. 1650, Sect. 4, Taiwan Boulevard, Taichung, 407, Taiwan. jonyin@gmail.com.; Doctoral Program in Translational Medicine, National Chung Hsing University, No. 145, Xingda Rd., South Dist., Taichung, 402, Taiwan. jonyin@gmail.com.; Rong Hsing Translational Medicine Research Center, National Chung Hsing University, No. 145, Xingda Rd., South Dist., Taichung, 402, Taiwan. jonyin@gmail.com.
Source: Targeted oncology [Target Oncol] 2026 Jun 08. Date of Electronic Publication: 2026 Jun 08.
Publication Type: Journal Article
Journal Info: Publisher: Springer-Verlag France Country of Publication: France NLM ID: 101270595 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1776-260X (Electronic) Linking ISSN: 17762596 NLM ISO Abbreviation: Target Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1776-260X
DOI:10.1007/s11523-026-01224-1